The Plasmodium falciparum circumsporozoite protein produced in Lactococcus lactis is pure and stable
Open Access
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (2) , 403-414
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African InfantsNew England Journal of Medicine, 2012
- Unexpected fold in the circumsporozoite protein target of malaria vaccinesProceedings of the National Academy of Sciences, 2012
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African ChildrenNew England Journal of Medicine, 2011
- A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2 – A GLURP–MSP3 fusion protein malaria vaccine candidateVaccine, 2011
- A Research Agenda to Underpin Malaria EradicationPLOS Medicine, 2011
- Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine CandidateJournal of Biological Chemistry, 2009
- Protective CD8+ T cells against Plasmodium liver stages: immunobiology of an ‘unnatural’ immune responseImmunological Reviews, 2008
- Cell-Passage Activity Is Required for the Malarial Parasite to Cross the Liver Sinusoidal Cell LayerPLOS Biology, 2004
- Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malariaNature, 1989
- Expression of Plasmodium falciparum Circumsporozoite Proteins in Escherichia coli for Potential Use in a Human Malaria VaccineScience, 1985